Press Releases

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Zillow Group, Inc. (NASDAQ:Z, ZG)) failed to manage Zillow in an acceptable manner, breaching their fiduciary duties to Zillow, and whether Zillow and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:On September 30, 2025, the Federal Trade Commission filed a lawsuit against Zillow, accusing Zillow of paying Redfin over $100 million for Redfin to stop competing for the sale of rental housing ads. Several states then brought their own suits on similar behavior.If you own Zillow common st

KUALA LUMPUR, Malaysia, June 11, 2026 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ:TGL) ("Treasure Global" or the "Company"), a Southeast Asia–anchored technology company focused on AI-powered enterprise solutions and digital transformation, today announced that it has been awarded a US$15 million contract by Creative World Industries Sdn Bhd ("Creative World Industries") to develop and deploy an enterprise-grade Social Listening AI System. The engagement marks a significant step in the Company's transition toward higher-value, AI-driven enterprise revenue streams. Creative World Industries is a Malaysia-based technology and infrastructure solutions company incorporated in 2001 with e

CrowdStrike ranked highest in Growth and Innovation among all vendors as runtime-first security becomes the standard for cloud and AI workload protection CrowdStrike (NASDAQ:CRWD) today announced it has been named the Growth and Innovation Leader in the 2026 Frost Radar™: Cloud and Application Runtime Security for the second consecutive time, scoring highest of all vendors evaluated. As AI workloads and frontier model risk expose the limits of posture-only defense, organizations are turning to runtime-first security on the CrowdStrike Falcon® platform to stop breaches in real time. Frost & Sullivan highlighted "CrowdStrike's growth in runtime security is supported by the broader market

AMSTERDAM and BOSTON, June 11, 2026 /PRNewswire/ -- Stellantis has incorporated Factorial's advanced solid-state battery cells into a Stellantis development vehicle - the first automotive integration of the technology in North AmericaRoad testing now underway to validate performance, safety and reliability under real-world conditionsBattery pack leverages a patented mechanical architecture to accommodate solid-state cellsMilestone marks the first vehicle in the previously announced multi-stage development vehicle programStellantis and Factorial Inc. (Factorial) (NASDAQ:FAC) have reached a significant milestone: the integration

Webcast occurring at 12:00pm ET on Thursday, June 18, 2026. Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), today announced that it will participate in the TD Cowen Medical Devices Emerging Growth Call Series at 12:00pm ET on June 18, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer and David Horsley, SVP, Innovation, will take part in the discussion. To register or access the audio-only webcast, visit the Events & Presentations section of the Butterfly investor website (https://ir.butterflynetwork.com/events-and-presentations). About Butterfly Network Butterfly Network, Inc. (NYSE:BFLY) is driving a digital revolution

Hospitality leaders will share innovative approaches to AI, guest personalization and revenue optimization on stage and at booth #1438 during the industry's largest hospitality technology conference. Agilysys, Inc. (NASDAQ:AGYS), a leading global provider of hospitality technology solutions and services, today announced that it will present three educational sessions at HITEC 2026, taking place June 15-18 in San Antonio, Texas. Led by Agilysys Senior Vice President of Product Strategy and CMO Frank Pitsikalis and Vice President, Sales Engineering, Thor Hansen, the sessions will examine how hospitality organizations are using connected data, created by the Agilysys ecosystem of modern so

Blood-based liquid biopsy test enables identification of patients eligible for treatment with HERNEXEOS® (zongertinib tablets) Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx as a companion diagnostic (CDx) for Boehringer Ingelheim's HERNEXEOS® (zongertinib tablets), the first targeted therapy for adults with HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NSCLC) as an initial treatment option. The approval enables Guardant360 CDx, a liquid biopsy test that analyzes circulating tumor DNA (ctDNA) from a simple blood draw, to identify patients with HER2 (ERBB2)

PLAINVIEW, N.Y., June 11, 2026 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ:VECO), a global leader in compound semiconductor process equipment, today announced the first commercial acceptance and qualification of its LUMINA+ metal organic chemical vapor deposition (MOCVD) system by Ennostar Corporation, a leader in optoelectronic semiconductors. The order sets a new benchmark for high-volume arsenide and phosphide (As/P) production. "We see LUMINA+ as a game-changer for the fast-growing As/P market," said Anil Vijayendran, Vice President of MOCVD Product Line Management at Veeco. "It's validation by an industry expert like Ennostar that effectively positions Veeco as a leader in ena

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY), today announced that six abstracts in narcolepsy and idiopathic hypersomnia have been accepted for poster presentation at SLEEP 2026, the 40th annual meeting of the Associated Professional Sleep Societies (APSS), which will be held June 14 – 17 in Baltimore, MD. The poster presentation details are as follows: Abstract Title Poster Presentation Session Treatment with Pitolisant in Subgroups of Adults with Narcolepsy: Pooled Analysis of Two Randomized Clinical Trials P-16 (Poster #387), 6/15/2026, 10:00-10:45 a.m. Effect of Pitolisant on Sleep Patterns in Idiopathic Hypersomnia: Analysis of Phase 3 Trial Sleep

License allows the Company to commence large-scale extraction of castanospermine from the seeds of Castanospermum australe Company will meet with FDA on July 1, 2026, to discuss Non-Notified Letter issued by the Agency in response to the Company's recent New Dietary Ingredient Notification (NDIN) to market Australian Chestnut Extract in the U.S. WASHINGTON, June 11, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP, SXTPW)) (the "Company" or "60 Degrees Pharma"), a pharmaceutical company focused on developing new medicines for vector-borne disease, announced that the Company has executed a patent licensing agreement with Florida State University to commence large-scal

– 12-month OS rate 94% among NPM1-m AML patients and 71% among KMT2A-r AML patients in single-arm KOMET-007 trial – – 96% CRc in newly diagnosed NPM1-m AML; 90% CRc in newly diagnosed KMT2A-r AML – – High rates of MRD negativity among NPM1-m AML responders assessed by both local assays and central testing – – Median OS not reached in either NPM1-m or KMT2A-r population with median follow-up of 17.6 months and 11.0 months, respectively – – 12-month survival rate, remission rates, MRD negativity, durability of CR and tolerability compare favorably to 7+3 precedents and strengthen confidence in ongoing KOMET-017 Phase 3 registrational study – – Kura to host a virtual investor event tomorro

AVENTURA, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- Safe Pro Group Inc. (NASDAQ:SPAI) ("Safe Pro" or the "Company"), a developer of artificial intelligence (AI)-enabled defense, security, and situational awareness solutions, announced today that it will be providing operational support to soldiers during an upcoming Army airfield exercise. At the event, Safe Pro will be demonstrating how its recently delivered AI-powered threat detection technology can be a force multiplier for rapid airfield operations. This new application of the Company's AI technology significantly expands its potential utilization into global airfield operations in addition to its current use in battlefield and post-con

Vancouver, British Columbia--(Newsfile Corp. - June 11, 2026) - Cosa Resources Corp. (TSXV:COSA) (OTCQB:COSAF) (FSE: SSKU) ("Cosa" or the "Company") is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting"), held on June 10, 2026. Shareholders voted in favour of all matters of business before the Meeting. Each of those matters is set out in detail in the Management Information Circular published in connection with the Meeting, which is available on the Company's website www.cosaresources.ca.A total of 37,017,237 common shares, representing approximately 31.5% of the Company's outstanding common shares, were voted in person and by pr

Investment From Existing Investor Reinforces Confidence in Brenmiller's Commercial Progress and Supports Execution of Its BNRG360 Growth StrategyTel Aviv, Israel--(Newsfile Corp. - June 11, 2026) - Brenmiller Energy Ltd. (NASDAQ:BNRG) ("Brenmiller" or the "Company"), a leading global provider of thermal energy storage ("TES") solutions for industrial and utility customers, today announced an investment arrangement with an existing investor expected to provide up to $2.5 million of additional capital to support the continued execution of its BNRG360™ growth strategy.The arrangement includes an immediate $1.5 million investment through convertible preferred shares with an initial conversion pr

-- Single dose of vispa-cel produced durable responses in 2L LBCL patients: 82% ORR, 67% CR rate, and 17.1-month mPFS -- -- Generally well-tolerated safety profile continues to support outpatient administration and further expansion to community centers -- -- ANTLER-3 pivotal phase 3 trial designed to address the unmet need in 2L LBCL patients at academic and community centers who lack treatment options with curative intent -- -- EHA oral presentation scheduled for Friday, June 12, 2026, at 5:15pm CEST -- BERKELEY, Calif., June 11, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced

New York, New York--(Newsfile Corp. - June 11, 2026) - Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Universal Health Services, Inc. (NYSE:UHS) failed to manage Universal Health in an acceptable manner, breaching their fiduciary duties to Universal Health, and whether Universal Health and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation-what shareholders need to know:On May 26, the Capitol Forum reported that South Carolina regulators flagged one of Universal Health's facilities multiple times, alleging the company failed to prevent sexual assaults of juvenile

Global professional services leader will leverage embedded AI to enhance hiring experiences and scale recruiting across 60+ countriesAUSTIN, Texas, June 11, 2026 /PRNewswire/ -- Cognizant, a leading global professional services company and longstanding Oracle partner, has selected Oracle Fusion Cloud Recruiting, part of Oracle Fusion Cloud Human Capital Management (HCM), to help power a more AI-driven approach to talent acquisition. With Oracle Recruiting, Cognizant aims to transform its talent acquisition journey, improve hiring efficiency, and scale recruiting operations to support its global workforce. Cognizant is one of th

NEW YORK, June 11, 2026 /PRNewswire/ -- Shutterstock, Inc. (NYSE:SSTK), a family of brands delivering scalable creative and GenAI solutions to help customers fuel great work, today unveiled the next evolution of its content library into a human-led, AI-powered creative platform. The advanced creative system combines premium human-made content, AI-powered creation tools, and intuitive workflows to help creatives move from idea to impact without starting from scratch. As businesses and creators adopt AI, many are looking for ways to move faster without sacrificing authenticity, creative control, or commercial confidence. Shutters

Across select amphitheaters nationwide, Lowe's is giving loyalty members exclusive perks and new ways to connect through live music all year longMOORESVILLE, N.C., June 11, 2026 /PRNewswire/ -- Lowe's is bringing MyLowe's Rewards* and MyLowe's Pro Rewards* members exclusive live music experiences through a new multi-year partnership with Live Nation. Members can access exclusive concert perks throughout the season, including discounted kids tickets† with purchase of an adult lawn ticket, complimentary lawn chair rentals at select shows for the first fifty eligible members^ and sweepstakes for a chance to win free tickets all year long. Helping members get more from the experiences they value

DXC is a Global Premier partner in the Claude Partner Network, creating new global domain-specific AI offerings for key industries.Claude is already powering DXC OASIS, the company's AI-native orchestration platform for managed services, now in production with more than 50 joint customers. With a workforce of over 115,000 across 70 countries, DXC and Anthropic are deepening their existing relationship to bring Claude inside the mission-critical systems and platforms DXC operates for the world's largest enterprises and governments.  Partnership establishes a new DXC workforce of Claude-certified forward-deployed engineers and builders to be embedded directly in customer environments to accele